Compression Works Investor Update & Deep Dive

Compression Works is the developer and manufacturer of the AAJT-S, the abdominal aortic and junctional tourniquet – stabilized. We offer the world’s only multi-functional life saving tourniquet for application in the axilla, on the abdomen, in the inguinal region and for control of junctional and pelvic bleeding as well as pelvic fracture stabilization and aortic compression proven to be equivalent to Zone 3 REBOA. Featured in over 70 scientific publications, the AAJT-S is the most studied device in its class and the only device proven to have saved life in both upper and lower junctional bleeding.

This session provides an opportunity for RVC portfolio company, Compression Works, to update existing RVC Investors while engaging those interested in the current follow-on investment.

The RVC Deep Dive is a 90 minute virtual meeting held between company executive leadership, RVC Investors, and RVC staff. The purpose of this meeting is to cover all major due diligence questions such as business strategy, team, product, competition, IP, market, traction, key risks, and exit strategy. 

The structure of the meeting is as follows:

• Company Pitch (15 minutes)
• Guided Q&A w/ Investors (45 minutes)
• Investor Only Discussion (30 minutes)

To attend, you must be an accredited investor (net worth of at least one million US dollars, not including the value of one’s primary residence, or have made at least $200,000 each year for the last two years [or $300,000 together with his or her spouse if married] and have the expectation to make the same amount this year). We do not require a minimum investment.